| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
|
J Clin Oncol
|
2008
|
7.01
|
|
2
|
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
|
JAMA
|
2008
|
4.61
|
|
3
|
NCCN Clinical Practice Guidelines in Oncology: colon cancer.
|
J Natl Compr Canc Netw
|
2009
|
4.41
|
|
4
|
NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
|
J Natl Compr Canc Netw
|
2009
|
3.37
|
|
5
|
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.
|
J Natl Compr Canc Netw
|
2013
|
3.03
|
|
6
|
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
|
J Clin Oncol
|
2009
|
2.66
|
|
7
|
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
|
J Clin Oncol
|
2006
|
2.42
|
|
8
|
Esophageal and esophagogastric junction cancers.
|
J Natl Compr Canc Netw
|
2011
|
2.03
|
|
9
|
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
|
J Clin Oncol
|
2004
|
1.86
|
|
10
|
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.70
|
|
11
|
Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012.
|
J Clin Oncol
|
2006
|
1.56
|
|
12
|
Pancreatic adenocarcinoma.
|
J Natl Compr Canc Netw
|
2010
|
1.52
|
|
13
|
Digital tomosynthesis with an on-board kilovoltage imaging device.
|
Int J Radiat Oncol Biol Phys
|
2006
|
1.42
|
|
14
|
Role of radiation therapy in patients with resectable pancreatic cancer.
|
Oncology (Williston Park)
|
2011
|
1.42
|
|
15
|
Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.41
|
|
16
|
Gastric cancer.
|
J Natl Compr Canc Netw
|
2010
|
1.35
|
|
17
|
Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of Radiation Therapy Oncology Group trials 87-04 and 98-11.
|
J Clin Oncol
|
2010
|
1.19
|
|
18
|
Pancreatic adenocarcinoma. Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2007
|
1.05
|
|
19
|
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
|
J Clin Oncol
|
2009
|
1.04
|
|
20
|
Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.02
|
|
21
|
NCCN clinical practice guidelines in oncology. Anal carcinoma.
|
J Natl Compr Canc Netw
|
2010
|
1.00
|
|
22
|
Detection of stool DNA mutations before and after treatment of colorectal neoplasia.
|
Cancer
|
2006
|
0.99
|
|
23
|
Colon cancer.
|
J Natl Compr Canc Netw
|
2011
|
0.96
|
|
24
|
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.
|
J Natl Compr Canc Netw
|
2012
|
0.96
|
|
25
|
Esophageal cancer.
|
J Natl Compr Canc Netw
|
2008
|
0.93
|
|
26
|
Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy.
|
Ann Surg Oncol
|
2011
|
0.91
|
|
27
|
Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.
|
Curr Oncol Rep
|
2011
|
0.90
|
|
28
|
Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
|
J Natl Compr Canc Netw
|
2005
|
0.85
|
|
29
|
Multiple etiologies of tumor hypoxia require multifaceted solutions.
|
Clin Cancer Res
|
2007
|
0.83
|
|
30
|
Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.82
|
|
31
|
Current and emerging treatment strategies for anal cancer.
|
Curr Oncol Rep
|
2010
|
0.82
|
|
32
|
Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.
|
Onco Targets Ther
|
2012
|
0.82
|
|
33
|
Evaluation of an artificial intelligence guided inverse planning system: clinical case study.
|
Radiother Oncol
|
2007
|
0.81
|
|
34
|
Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers.
|
J Natl Compr Canc Netw
|
2008
|
0.77
|
|
35
|
IMRT treatment of anal cancer with a scrotal shield.
|
Med Dosim
|
2012
|
0.76
|
|
36
|
Upper gastrointestinal tract.
|
Cancer Treat Res
|
2006
|
0.75
|
|
37
|
Pancreatoblastoma in a teenage patient.
|
Clin Adv Hematol Oncol
|
2006
|
0.75
|